CompoAtlas

Estragon huile essentielle

Food supplement declared in France, decision dated 10 February 2026

Estragon huile essentielle, from LABORATOIRES CEORA, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Artemisia dracunculus 10 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
not provided
Food business operator placing the product on the market
LABORATOIRES CEORA
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Bottle
Daily dose
10 mg

Declaration 353339, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Artemisia dracunculus L.Essence (sommités fleuries)Distillation10 mg

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Estragon huile essentielle: composition and regulation”, https://compoatlas.com/en/supplements/products/353339-estragon-huile-essentielle, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line